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Abstract
Background: The aim of this study is to quantify the hospital burden of COVID-19 during the first wave and how it
changed over calendar time; to interpret the results in light of the emergency measures introduced to manage the
strain on secondary healthcare.
Methods: This is a cohort study of hospitalised confirmed cases of COVID-19 admitted from February–June 2020
and followed up till 17th July 2020, analysed using a mixture multi-state model. All hospital patients with confirmed
COVID-19 disease in Regione Lombardia were involved, admitted from February–June 2020, with non-missing
hospital of admission and non-missing admission date.
Results: The cohort consists of 40,550 patients hospitalised during the first wave. These patients had a median age
of 69 (interquartile range 56–80) and were more likely to be men (60%) than women (40%). The hospital-fatality
risk, averaged over all pathways through hospital, was 27.5% (95% CI 27.1–28.0%); and steadily decreased from
34.6% (32.5–36.6%) in February to 7.6% (6.3–10.6%) in June. Among surviving patients, median length of stay in
hospital was 11.8 (11.6–12.3) days, compared to 8.1 (7.8–8.5) days in non-survivors. Averaged over final outcomes,
median length of stay in hospital decreased from 21.4 (20.5–22.8) days in February to 5.2 (4.7–5.8) days in June.
Conclusions: The hospital burden, in terms of both risks of poor outcomes and lengths of stay in hospital, has
been demonstrated to have decreased over the months of the first wave, perhaps reflecting improved treatment
and management of COVID-19 cases, as well as reduced burden as the first wave waned. The quantified burden
allows for planning of hospital beds needed for current and future waves of SARS-CoV-2 i.
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Introduction
On the 9th of January 2020, the health authorities in
China reported that a novel strain of coronavirus, later
named SARS-CoV-2, was the causative agent for many
of the severe acute respiratory syndromes occurring in
the area of Wuhan [1]. In response to the emerging situ-
ation, several pre-pandemic measures were implemented
by the Italian Ministry of Health and by Regione
Lombardia.
In Lombardia, seventeen “first-responder hub hospi-
tals” were selected to be part of the Infectious Disease
Hospital Network and charged with admission of sus-
pected cases, because of their expertise in infectious dis-
eases or their membership of the Venous-venous ECMO
Respiratory Failure Network [2]. General Practitioners
and Family Pediatricians received training on surveil-
lance activities [3]; temperature scanners were set up in
airports to screen passengers from in-bound flights; and
an Operations Room for Emergencies was organised to
manage emergency calls from suspected Covid-19 pa-
tients [4].
On 20/02/2020 the first Italian patient was diagnosed
with Covid-19 in the Lombardia town of Codogno,
which soon became the Italian epicenter of the pan-
demic. The number of confirmed infected patients rose
to 403 by the following week, with 213 patients admitted
to hospitals [5]. This abrupt rise in the number of con-
firmed cases, peaking eventually on the 20th of March
2020, put a large strain on the healthcare system in
Lombardia [6], an Italian region of approximately 10
million inhabitants of whom 41% over 55 years of age
(Additional file 1: Appendix A.1.1). The growing need
for hospital capacity led to non-urgent procedures being
cancelled (48 h after the first case) and to expanding the
number of beds, especially in the ICU wards, where the
pre-crisis capacity was around 720, immediately raised
to 861 [2]. Regional Coordination Units were created
(Additional file 1: Appendix A.1.3) to manage the crisis.
The Regional Unit of Coordination for Hospital Admis-
sion collected data on the number of vacant beds daily
and redirected patients with the purpose of redistribut-
ing the burden equally among the 17 first-responder
hub hospitals (the “hub-and-spoke” model) especially in-
volved during the initial phase of the pandemic and then
among all hospitals in the region. A total of 482 ICU
beds were made available over 18 days from the 20th
February [2].
All of the enacted emergency measures likely impacted
on the ability of the healthcare system of Lombardia to
provide care. The aims of this study are: to estimate how
mortality risk and progression of patients through hos-
pital changed through the first wave; to interpret these
changes in relation to the emergency measures imple-
mented; and to inform management and relevant models
of the next waves, currently in progress. The burden is
quantified, using a multi-state modelling approach [7],
in terms of risks of progression through hospitals of




The Covid-19 Regional Database (Additional file 1: Ap-
pendix A.1.3) is an integrated database collecting data
from laboratories, hospitals and Local Healthcare Agen-
cies and comprises detailed, but pseudo-anonymised,
retrospective individual-level data on the cohort of all
individuals in Lombardia diagnosed with Covid-19 dur-
ing the first wave from February to June 2020 [8–10].
Data, as extracted on 5th August 2020, include 95,777
records, representing 95,354 individuals with confirmed
COVID-19 disease in 2020, observed from 1st December
2019 to 17th July 2020. The dataset records age, gender,
Local Healthcare Agency district of Lombardia, co-
morbidities, symptoms, whether the individual is a
healthcare worker or care home resident, whether or not
the individual was hospitalised, and details of the admit-
ting hospital if the individual was hospitalised. For each
individual, dates of symptom onset, positive laboratory
test, hospital admission, ICU admission, ICU discharge,
hospital discharge, recovery and death are recorded. Ex-
cluding duplicate records and records with inconsistent,
missing or invalid dates leaves 94,474 individuals, of
whom 46,609 were hospitalised. Finally, excluding the
12.4% of hospitalised patients with missing hospital of
admission leaves 40,550 individuals in the dataset.
Multi-state model
The progression of patients through hospital can be rep-
resented by a multi-state model with states Hospital
(ward entered on admission date), ICU (entered at ICU
admission), Post-ICU (entered after ICU discharge), Dis-
charge (entered on date of hospital discharge), and
Death (entered on date of death) (Additional file 1: Ap-
pendix Fig. A.2). The outcomes of interest are: the prob-
abilities of entering each next state (a “next event”) given
the current state; the probabilities of entering a final
state (either a Death or Discharge event) given hospital
admission (“hospital-fatality risk”, defined in Additional
file 1: Appendix A.4) or given the current state; corre-
sponding times to each next event, conditional on ex-
periencing the next event, i.e. the lengths of stay in each
state; and the total length of stay (LoS) in hospital.
The multi-state model is implemented as a “mixture
model” [7, 11], combining multinomial or binomial lo-
gistic regression of probabilities of different pathways
through hospital on covariates with parametric time-to-
event analyses for the time taken to move from one state
Grosso et al. BMC Public Health         (2021) 21:1612 Page 2 of 9
to the next (each LoS), conditional on the next event oc-
curring. Analyses are carried out in R 3.6.3 using the
flexsurv package [7].
In the Covid-19 Regional Database, outcomes/next
events are missing for < 1% of individuals in the Hospital
and ICU states, and for 15% of individuals in the Post-
ICU state (Additional file 1: Appendix Fig. A.1). It is un-
known why outcomes are missing, i.e. whether they had
not happened by the end-date of the data, 17th July,
(“right-censoring”), or whether they had not been re-
corded (“missing data/loss to follow-up”). Since it is im-
possible to distinguish between these possibilities, two
alternative assumptions are made: (1) the missing out-
comes are ignorable, i.e. individuals with missing out-
comes have the same distribution of outcomes as those
observed; (2) these individuals are right-censored at a
time t after their last observed event. In this second case,
the parametric time-to-event models account for the
censoring, and typically t would be the length of time till
the end of the dataset, i.e. till 17th July. However, we
judge that it is implausible that all of those with missing
outcomes are still in hospital by mid-July, so instead
make the conservative assumption that t is 1 day. The
results are very similar under the two assumptions (Add-
itional file 1: Appendix A.3), so in what follows, only the
results under assumption [2] are reported. As we con-
sider discharge a final outcome, we ignore the 2.02% of
discharged patients who are observed to die after dis-
charge (Additional file 1: Appendix Fig. A.1).
We consider four models with different covariate com-
binations: (a) no covariates; (b) month of hospital admis-
sion; (c) hospital bed capacity; (d) both month of
hospital admission and hospital bed capacity. Bed cap-
acity is defined in terms of numbers of both hospital and
ICU beds (Additional file 1: Appendix Table A.3). Point
estimates and 95% confidence intervals (CIs) are re-
ported for each probability of interest, as well as for the
median and interquartile ranges (IQRs) of each time-to-
event distribution. The confidence intervals represent
parameter uncertainty, whereas the median and IQRs
summarise the heterogeneity across individuals in the
time-to-event distributions.
These models do not account for individual patient char-
acteristics, which are explored in a companion paper [12].




The cohort consists of 40,550 individuals who under-
went hospitalization during the first wave. Their median
age was 69 (interquartile range [56–80]); the proportion
of men (60%) was higher than women (40%); most (69%)
were admitted in March; 64% had at least one co-
morbidity; 4% were care home residents; 4% were
healthcare workers; and most (71%) were admitted to
hospitals with a large bed capacity. Further covariate
summaries for these patients are shown in Additional
file 1: Appendix (Table A.4).
Overall results
Figure 1 shows the specific hospital-fatality risks from
each state: 23.1% (22.7–23.5%) from hospital without
ICU; 42.5% (40.8–43.9%) from ICU; and 9.8% (9.0–
11.0%) from post-ICU. When averaged over all pathways
through hospital, the overall hospital-fatality risk was
27.5% (95% CI 27.1–28.0%).
The overall median (95% CI of median) LoS in hos-
pital, averaged over all pathways through hospital and
final outcomes was 10.4 (10.1–10.9) days. Among surviv-
ing patients, median LoS in hospital was 11.8 (11.6–
12.3) days, while those whose final outcome was death
had a median time to death of 8.1 (7.8–8.5) days.
The probability of ICU admission was 9.2% (9.0–9.5%)
and the corresponding median time from hospital ad-
mission to ICU admission was 3.5 (3.3–3.6) days. The
median LoS in ICU was 11.0 (10.7–11.6) days: 12.6
(12.2–13.2) days for survivors and 9.6 (9.3–10.1) days for
non-survivors. The median LoS in a post-ICU ward was
18.0 (17.1–18.7) days: 18.8 (18.2–19.5) days for survivors
and 10.1 (8.9–11.9) days for non-survivors. By pathway
through hospital, median LoS in hospital was: 10.8
(10.3–10.9) days for surviving patients who were not ad-
mitted to ICU (hospital-discharge); 40.7 (40.1–41.8) days
for surviving patients who were admitted ICU (hospital-
ICU-postICU-discharge); 6.9 (6.6–7.1) days for non-
survivors who were not admitted to ICU (hospital-
death); 15.1 (14.8–15.9) days for patients who died in
ICU (hospital-ICU-death); and 31.7 (30.0–33.0) days for
patients who died in a post-ICU ward (ward-ICU-post-
ICU-death).
By month of admission
Figure 2 shows the estimated odds ratios of risk of next
events by month compared to a baseline of March, to-
gether with corresponding predicted probabilities of next
events, demonstrating the overall decreasing trend in se-
vere events. The probability of ICU admission from a
hospital ward decreased from 14.3% (13.0–16.0%) in
February to 2.6% (1.7–3.6%) in June; the hospital-fatality
risk without ICU decreased from 25.7% (24.1–27.6%) in
February to 6.6% (5.0–8.0%) in June; and the ICU-
fatality risk decreased from 46.0% (41.5–52.8) in Febru-
ary to 26.1% (17.6–36.4%) in May–June.
The trend in fatality risk is more uncertain from the
post-ICU state, with only February (at 30.6% [23.5–
37.6%]) significantly higher than March (8.4% [7.6–
9.7%]), and the post-ICU-fatality risk estimated to be
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15.1% (7.8–29.9%) in May–June. Assuming the same
risks of death from ICU or post-ICU in May and June,
the overall hospital-fatality risk, regardless of path
through hospital, is estimated to have steadily decreased
from 34.6% (32.5–36.6%) in February to 29.8% (29.3–
30.3%) in March, 22.0% (21.1–23.0%) in April, 14.7%
(13.3–15.9%) in May and 7.6% (6.3–10.6%) in June.
The overall median LoS in hospital, regardless of out-
come, decreased from 21.4 (20.5–22.8) days in February
to 5.2 (4.7–5.8) days in June. Among survivors, median
LoS in hospital, whether or not they had an ICU admis-
sion, decreased from 24.6 (22.8–26.1) days in February
to 5.1 (4.8–5.8) days in June. Non-survivors had slightly
shorter median LoS, decreasing from 17.8 (17.1–19.9)
days in February to 4.7 (3.3–6.0) days in June.
The median times spent by survivors in different
stages of hospital (pre-ICU, ICU, and post-ICU) also ap-
pear to have decreased with calendar month of admis-
sion (Fig. 3). The median time to ICU admission
decreases from 2.8 (2.5–3.3) days in February to 1.0
(0.6–1.6) days in June. Median LoS in hospital among
survivors who were not admitted to ICU reduced from
22.4 (21.1–23.6) days in February to 5.1 (4.7–5.6) days in
June; median LoS in ICU among survivors reduced from
10.3 (9.1–13.0) days in February to 7.5 (6.6–9.7) days in
May–June, although it was longest in March, at 12.8
(12.3–13.4) days. Heterogeneity amongst survivors in
their lengths of stay also appears to have decreased with
month of admission (dashed lines in Fig. 3).
There is no clear trend in non-survivors who are not
admitted to ICU: the median time to death is largest in
February, at 18.0 (16.4–19.8) days, dropping to 5.5 (5.4–
5.6) days in March, but then doesn’t appear to change
significantly from March through to June. Similarly, the
times to death from ICU and from a post-ICU stay do
not appear to vary much with month of admission.
Effect of hospital bed capacity
Hospital size, in terms of bed capacity, has a (un-
adjusted) significant effect on the probabilities of next
events from hospital admission: the smallest hospitals
have both the lowest risk of ICU admission (odds ratio
0.450 [0.400–0.506] relative to the largest) and a slightly
lower risk of death without ICU admission (odds ratio
0.773 [0.723–0.827]) (Fig. 4). These lower risks corres-
pond to a higher probability of discharge among small
hospitals (Fig. 4). However, note that the majority of the
smallest hospitals have zero ICU beds, so the lower risk
of ICU admission may be an artefact of not having the
capacity. The risk of death in ICU is also significantly
smaller in the smallest hospitals compared to the largest
(odds ratio 0.292 [0.220–0.386]), but may again be an
artefact of the lower ICU capacity. Hospital bed capacity
has no significant effect on risks of next events after a
post-ICU stay. These risks combine to result in a
hospital-fatality risk that is lowest in small hospitals:
21.4% (20.6–22.3%) compared to 30.2% (29.0–31.5%)
Fig. 1 Multi-state model with estimated risks (point estimate and 95% CI in brackets) of moving from current states to next events. The numbers
in each state in square brackets are the observed numbers of patients reaching each state. These observed numbers do not include the numbers
of patients with missing next events (< 1% in the Hospital and ICU states, 15% in the Post-ICU state), nor the ignored 2% of patients who died
after being discharged from hospital. In contrast, the estimated risks account for the missing next events, assuming they are censoring at 1 day
after the patients’ last observed events
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and 28.4% (27.9–28.9%) in medium and large hospitals
respectively.
LoS for survivors in hospital without ICU and in a
post-ICU ward become shorter as hospital bed capacity
becomes larger, with small but significant effects (Fig. 5,
top-left panel), whereas LoS in ICU does not vary signifi-
cantly (Fig. 5, bottom-left panel). The effect of hospital
bed capacity on time to death from hospital without
ICU is marginally significant, but with only a small effect
resulting in only a day’s difference between small and
large hospitals. In ICU and post-ICU wards, the time to
death does not vary by bed capacity (Fig. 5, bottom-right
panel). Averaged over all pathways through hospital, me-
dian LoS is 13.7 (13.2–14.2) days in small hospitals, 10.4
(10.1–10.7) days in medium hospitals, and 9.7 (9.4–9.9)
days in large hospitals. This effect of hospital bed cap-
acity appears significant for survivors (11.1 [10.8–11.7],
13.0 (12.3–13.3) and 16.6 (16.0–17.8) days respectively
for large, medium and small hospitals), but not for non-
survivors: time to death is 7.0 (6.6–7.3), 7.5 (6.7–7.6)
and 7.6 (6.8–8.0) days respectively.
When adjusting for both hospital bed capacity and
month of admission simultaneously, our findings are
similar to the univariable results in Sections 3.3 and 3.4
(Additional file 1: Appendix A.3.4).
Discussion
This analysis has demonstrated substantial changes in
the hospital burden of COVID-19 disease in Lombardia
over the first wave. Quantifying burden is paramount for
contingency planning in terms of beds, equipment and
staff needed in hospitals. Figure 1 shows the proportion
of patients that will most likely experience each outcome
after admission, that is 9.2% (9.0–9.5%) will undergo
ICU admission, a proportion that is much lower than
the 24% reported by Boelle et al. [13]. In contrast, 67.8%
(67.4–68.0%) will be discharged without ICU admission,
a number that is comparable to the 63% found by Boelle
Fig. 2 Estimated odds ratios (odds of next event in each month compared to the odds of next event in March) and predicted probabilities of
moving from the current state (columns) to next events (colours). Points are point estimates and vertical bars represent 95% confidence intervals.
Note that for the ICU and post-ICU states, the observed numbers of events in June were small, so the “May” month includes events from both
May and June combined. Note also that odds ratios are presented for 2/3 or 1/2 of the next events, since the probability of the remaining event
(discharge in all three columns) is just defined as 1 minus the other probabilities
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et al. The outcome of death without ICU admission is
also slightly higher (23.1% [22.7–23.5%]) when compared
to Boelle et al. (13%).
At the peak of the first wave in March, the number of
hospitalized patients rose to 7387, 37.15% of the re-
ported positive cases (19,884, 10), although this ratio is
affected by a selection bias resulting from the early pol-
icy of preferential testing of symptomatic cases. Prelim-
inary work on extending the multi-state model to
estimate hospital admission risk amongst cases with
symptoms suggests 45.7% (45.2–46.1%) of symptomatic
cases in Milano ATS required hospital admission in the
first wave. Making the admittedly strong assumption
that these results are applicable more widely to Lombar-
dia, 45 beds might be expected to be needed for every
100 symptomatic cases. Moreover, our results suggest
that the majority of beds (almost 70% of the total hos-
pital admissions) should be planned for wards, while
around 10% of hospital admissions are expected to re-
quire ICU beds; post-ICU beds should number at least
60% of ICU beds (Fig. 1).
Length of stay (LoS) in hospital is also an important
measure to factor in when planning for an emergency.
Our estimates of both overall median length of stay in
hospital (10.4 days (10.1–10.9)) and in ICU (11.0 days
(10.7–11.6)) are comparable with the LoS reported in
the systematic review of Rees et al. [14] covering publi-
cations between 1 January 2020 and 12 April 2020. The
authors found a hospital LoS of 4 days (1–9) outside
China compared to 14 days (10–19) in China; and an
ICU LoS of 7 days (4–11 days) outside China compared
to 8 days (5–13) in China. The longer estimated LoS we
found for surviving patients, when compared to patients
whose final outcome was death, seems consistent with
observations in the review but only for overall median
length of hospitalization.
Decreases in the risks of severe events such as ICU ad-
mission and mortality have been estimated from Febru-
ary to June 2020, with corresponding increases in the
risks of the positive outcomes of discharge from either
ICU or hospital. Total LoS in hospital, averaged over
final outcome, has decreased over the same months.
Similarly, lengths of stay pre-ICU, in ICU, in hospital
overall for those not admitted to ICU, and in post-ICU
wards, among survivors who are eventually discharged,
have reduced over time. Moreover (Fig. 3), the time to
discharge, both from ordinary ward and from post-ICU,
is the measure changing most substantially over time.
These decreases, altogether, suggest an improvement in
patient management, supported by the progressive in-
crease in clinical knowledge of COVID-19 and a less se-
vere disease presentation at hospital admission, resulting
from prolonged and strict lockdown measures over the
course of 3 months. In contrast, there is less evidence of
any change in the lengths of stay for non-survivors and
furthermore, the effect of bed capacity on LoS is not sig-
nificant for non-survivors. This finding may indicate that
more frail patients were unfortunately largely impacted
by their condition and thus less responsive to the pro-
gressive amelioration of care, although no specific cure
has been found yet. The long LoS for patients on the
pathway hospital-admission-to-ICU-to-PostICU-to-dis-
charge (40.7 days [40.1–41.8]) may be affected by the
lack of downstream beds: during the first wave of the
pandemic, hospitals struggled to find facilities for post-
hospitalization care and rehabilitation. This shortage
Fig. 3 Summaries of the distributions of times from current state (columns) to next events (colours), by calendar month of admission. The 95% CI
of the median times (solid lines) represent uncertainty in the estimate, whereas the inter-quartile range of the distribution (dashed lines)
represents heterogeneity in the population
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might have affected discharges from hospitals, as also
hypothesized by Boelle et al. [13]. Regione Lombardia
has a high proportion of individuals older than 65 (Add-
itional file 1: Appendix A.1.1), including those resident
in care homes and long-term facilities, explaining the
scarcity of available post-hospital beds. Increasing the
number of beds in both long-term facilities and in post-
ICU wards where only low-grade assistance is needed,
would relieve hospitals and increase patient turnover.
Hospital size appears associated with length of stay, with
shorter stays in larger hospitals, at least for survivors, with
small but significant effects. This finding remains both
when adjusting for month of admission and when adjust-
ing additionally for patient characteristics such as age,
gender and co-morbidities [12]. The largest hospitals have
more beds, more patients and more skilled staff, and most
of them were among the 17 hospitals in the Covid-19 Net-
work. While the association may be confounded with the
different case-mix in smaller versus larger hospitals,
nevertheless, we posit that our finding reflects the imple-
mentation of the hub-and-spoke model: high-risk patients
transferred from smaller, less resourced hospitals to spe-
cialist, highly skilled hospitals with ICU beds, supporting
the “high case volume-better performances” model [15].
The evidence of hospital size effect is very important, as it
is a proxy of the effective impact of the emergency mea-
sures on hospital management and on patients’ lives, help-
ing inform the management of further pandemic waves.
Some assumptions and limitations to this analysis are inev-
itable. The 12% of cases without information on their admit-
ting hospital were excluded. The analysis assumes this
missingness is ignorable, i.e. that cases with missing hospital
information were similar to those with observed hospitals of
admission. Similarly, excluding patients with inconsistent
data on ICU admissions and discharges is assumed not to
have biased results in any way. Hospital bed capacity was de-
fined in terms of a combination of numbers of hospital and
ICU beds (see Additional file 1: Appendix Table A.3). Bed
capacity could have been defined in different ways, so results
could depend on this definition. The fact that a large propor-
tion of hospitals (over 50%) had zero ICU beds may also
have caused artefactual results in terms of the risk of ICU
Fig. 4 Estimated odds ratios (relative to large hospitals) and predicted probabilities of moving from the current state (columns) to next
events (colours)
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admission in small hospitals. Finally, the analysis presented,
assuming individuals with missing outcomes are censored 1
day after their last observed event, was demonstrated to be
very similar to assuming the missingness is ignorable. The
results might not have been as similar if a different censoring
assumption had been chosen, such as censoring individuals
with missing outcomes at the date of the data (17th July).
Such an assumption implies individuals being alive/next
event-free for a longer period of time than a single day, so es-
timates of times to next events would be expected to be lar-
ger, although estimated risks would be expected to be
similar to those under the 1-day censoring assumption, due
to low proportions censored.
Nevertheless, the presented estimates give crucial evi-
dence to support planning hospital care for the current
and any potential future wave of infection.
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